ORGJF (Organo) EBIT: $253 Mil (TTM As of Mar. 2026)


ORGJF Organo Corp ORGJF
87 GF Score
Price $100.46
GF Value $56.75
! 3 Warning Signs
View Full Analysis

What is Organo EBIT?

Organo ORGJF 87 EBIT is $253 Mil as of Mar. 2026. GuruFocus rates ORGJF with a GF Score™ of 87/100 and a GF Value™ of $56.75. The stock has 3 warning signs investors should review.

Organo's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was $76 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was $253 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Organo's annualized ROC % for the quarter that ended in Mar. 2026 was 32.75%. Organo's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 60.08%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Organo's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.81%.


Organo  (OTCPK:ORGJF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Organo's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=290.82 * ( 1 - 12.86% )/( (832.524 + 715.208)/ 2 )
=253.420548/773.866
=32.75 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1328.621 - 152.012 - ( 344.085 - max(0, 411.981 - 1127.858+344.085))
=832.524

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1417.086 - 166.779 - ( 535.099 - max(0, 447.049 - 1209.974+535.099))
=715.208

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Organo's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=303.324/( ( (140.512 + max(530.436, 0)) + (141.175 + max(197.577, 0)) )/ 2 )
=303.324/( ( 670.948 + 338.752 )/ 2 )
=303.324/504.85
=60.08 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(474.04 + 230.061 + 79.672) - (152.012 + 0 + 101.325)
=530.436

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(302.421 + 116.982 + 46.237) - (166.779 + 0 + 101.284)
=197.577

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Organo's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=253.459/4366.000
=5.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organo EBIT Related Terms


Organo EBIT Historical Data

* Premium members only.

The historical data trend for Organo's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organo EBIT Chart

Organo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 108.14 121.15 159.35 218.73 243.30

Organo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 78.90 45.51 74.59 57.53 75.83

ORGJF vs VLTO, ZWS, CECO: EBIT Comparison

For the Pollution & Treatment Controls subindustry, Organo's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organo EV-to-EBIT vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Organo's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Organo's EV-to-EBIT falls into.


ORGJF
87GF Score
Organo Corp ORGJF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organo EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $253 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $253 Mil mean?
Organo (ORGJF) has a EBIT of $253 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Organo.
Is Organo's EBIT too high?
Organo's current EBIT is $253 Mil. Overall, Organo has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Organo's EBIT compare to VLTO and ZWS?
Organo's EBIT of $253 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Industrial Products company?
A good EBIT depends on the Industrial Products industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Organo. Organo's current EBIT is $253 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organo stock overvalued right now?
Organo (ORGJF) has a current EBIT of $253 Mil. The stock's GF Value™ is $56.75, compared to a current price of $100.46 — trading 77% above its estimated fair value. The current EBIT is $253 Mil. Organo's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Organo (ORGJF), the current EBIT is $253 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organo (ORGJF) Overvalued in 2026?

Based on GuruFocus' analysis, Organo stock appears to be overvalued. The current stock price of $100.46 is trading 77% above its estimated GF Value™ of $56.75.

Key valuation signals for ORGJF:

  • EBIT: $253 Mil
  • GF Value™: $56.75 vs. price of $100.46 (77% above fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the ORGJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Organo Business Description

Other Exchanges 6368:Japan
Address 1-2-8 Shinsuna, Koto-ku, Tokyo, JPN, 136-8631
Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.
87GF Score

Get the complete analysis for ORGJF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$100.46
Price
$56.75
GF Value